In asthma and pulmonary hypertension, direct activation of CaSR with the polyamines and/or polycationic proteins increases cytosolic calcium signaling, smooth muscle cell proliferation, and hyperresponsiveness, all of which are abolished by genetic or pharmacological inhibition of CaSR [24,35,70]. The gene discussed is CASR; the disease is asthma.